GARY A. LYONS

Insider Reports History

Location
San Diego, CA
Signature
/s/ Darin Lippoldt, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by GARY A. LYONS:

Company Role Class Num Shares Value Price $ Report Date Ownership
NEUROCRINE BIOSCIENCES INC Director Common Stock 120,482 $18,386,215 $152.61 03 Dec 2025 Direct
Travere Therapeutics, Inc. Director Common Stock 57,500 $1,053,975 $18.33 15 May 2025 Direct
Eledon Pharmaceuticals, Inc. Director Common Stock 150,437 $673,958 $4.48 01 May 2023 Direct
RIGEL PHARMACEUTICALS INC Director Common Stock 75,000 $131,250 $1.75 26 May 2023 Direct
NEUROCRINE BIOSCIENCES INC Director Non-Qualified Stock Option 0 $0 $73.60 03 Dec 2025 Direct
Brickell Biotech, Inc. Director Stock Option (right to buy) 65,000 17 May 2022 Direct
RIGEL PHARMACEUTICALS INC Director Stock Option (Right to Buy) 30,000 26 May 2023 Direct
Travere Therapeutics, Inc. Director Stock option (right to buy) 19,500 15 May 2025 Direct
NEUROCRINE BIOSCIENCES INC Director Restricted Stock Unit 0 22 May 2025 Direct

Insider Reports Filed by GARY A. LYONS

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NBIX NEUROCRINE BIOSCIENCES INC 03 Dec 2025 3 -$1,570,732 4 Director 04 Dec 2025, 16:14
NBIX NEUROCRINE BIOSCIENCES INC 21 May 2025 4 $0 4 Director 22 May 2025, 17:18
TVTX Travere Therapeutics, Inc. 15 May 2025 2 $0 4 Director 16 May 2025, 19:00
TVTX Travere Therapeutics, Inc. 04 Oct 2024 4 -$169,901 4 Director 04 Oct 2024, 19:15
NBIX NEUROCRINE BIOSCIENCES INC 13 Aug 2024 3 -$1,245,716 4 Director 15 Aug 2024, 17:21
NBIX NEUROCRINE BIOSCIENCES INC 16 Jul 2024 3 -$99,763 4 Director 18 Jul 2024, 16:54
NBIX NEUROCRINE BIOSCIENCES INC 22 May 2024 2 $0 4 Director 23 May 2024, 18:17
NBIX NEUROCRINE BIOSCIENCES INC 17 May 2024 2 $0 4 Director 21 May 2024, 16:57
NBIX NEUROCRINE BIOSCIENCES INC 14 May 2024 3 -$1,695,370 4 Director 16 May 2024, 16:55
TVTX Travere Therapeutics, Inc. 08 May 2024 2 $0 4 Director 10 May 2024, 16:05
NBIX NEUROCRINE BIOSCIENCES INC 22 Dec 2023 1 -$1,300,443 4 Director 27 Dec 2023, 16:10
NBIX NEUROCRINE BIOSCIENCES INC 01 Dec 2023 3 -$583,837 4 Director 05 Dec 2023, 16:54
NBIX NEUROCRINE BIOSCIENCES INC 12 Sep 2023 3 -$575,120 4 Director 14 Sep 2023, 16:51
NBIX NEUROCRINE BIOSCIENCES INC 01 Sep 2023 3 -$550,316 4 Director 06 Sep 2023, 16:25
RIGL RIGEL PHARMACEUTICALS INC 26 May 2023 2 $0 4 Director 12 Jul 2023, 18:45
NBIX NEUROCRINE BIOSCIENCES INC 17 May 2023 2 $0 4 Director 19 May 2023, 17:15
TVTX Travere Therapeutics, Inc. 17 May 2023 2 $0 4 Director 19 May 2023, 16:05
ELDN Eledon Pharmaceuticals, Inc. 01 May 2023 1 $0 4 Director 02 May 2023, 18:44
ELDN Eledon Pharmaceuticals, Inc. 01 Feb 2023 1 $0 4 Director 02 Feb 2023, 17:07
NBIX NEUROCRINE BIOSCIENCES INC 31 Oct 2022 3 -$1,721,403 4 Director 02 Nov 2022, 18:42
NBIX NEUROCRINE BIOSCIENCES INC 04 Oct 2022 1 -$552,711 4 Director 05 Oct 2022, 19:00
RIGL RIGEL PHARMACEUTICALS INC 20 May 2022 2 $0 4 Director 23 May 2022, 17:50
NBIX NEUROCRINE BIOSCIENCES INC 18 May 2022 1 $0 4 Director 20 May 2022, 16:02
/report/000081905022000072-lyons-gary-a-2022-05-17 Brickell Biotech, Inc. 17 May 2022 1 $0 4 Director 17 May 2022, 17:15
TVTX Travere Therapeutics, Inc. 11 May 2022 2 $0 4 Director 12 May 2022, 20:24
NBIX NEUROCRINE BIOSCIENCES INC 25 Apr 2022 3 -$1,391,392 4 Director 27 Apr 2022, 17:26
ELDN Eledon Pharmaceuticals, Inc. 01 Feb 2022 1 $0 4 Director 02 Feb 2022, 16:33
NBIX NEUROCRINE BIOSCIENCES INC 07 Oct 2021 1 -$525,294 4 Director 12 Oct 2021, 18:34
/report/000081905021000084-lyons-gary-a-2021-06-14 Brickell Biotech, Inc. 14 Jun 2021 1 $0 4 Director 14 Jun 2021, 16:43
NBIX NEUROCRINE BIOSCIENCES INC 10 Jun 2021 1 -$1,002,743 4 Director 14 Jun 2021, 20:25
RIGL RIGEL PHARMACEUTICALS INC 19 May 2021 2 $0 4 Director 21 May 2021, 20:50
NBIX NEUROCRINE BIOSCIENCES INC 19 May 2021 1 $0 4 Director 20 May 2021, 16:03
TVTX Travere Therapeutics, Inc. 14 May 2021 2 $0 4 Director 18 May 2021, 21:22